|
1
|
Cui X, Liu F, Wang JQ, Zhang WJ, Wang JY,
Liu K, Cui SY, Zhang J and Xu RR: Complete sequence analysis of
mitochondrial DNA of aplastic anemia patients. Genet Mol Res.
11:2130–2137. 2012. View Article : Google Scholar
|
|
2
|
Chinnery PF and Schon EA: Mitochondria. J
Neurol Neurosurg Psychiatry. 74:1188–1199. 2003. View Article : Google Scholar
|
|
3
|
Richter C, Park JW and Ames BN: Normal
oxidative damage to mitochondrial and nuclear DNA is extensive.
Proc Natl Acad Sci USA. 85:6465–6467. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Penta JS, Johnson FM, Wachsman JT and
Copeland WC: Mitochondrial DNA in human malignancy. Mutat Res.
488:119–133. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grist SA, Lu XJ and Morley AA:
Mitochondrial mutations in acute leukaemia. Leukemia. 18:1313–1316.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Linnartz B, Anglmayer R and Zanssen S:
Comprehensive scanning of somatic mitochondrial DNA alterations in
acute leukemia developing from myelodysplastic syndromes. Cancer
Res. 64:1966–1971. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wulfert M, Küpper AC, Tapprich C, et al:
Analysis of mitochondrial DNA in 104 patients with myelodysplastic
syndromes. Exp Hematol. 36:577–586. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hatfill SJ, La Cock CJ, Laubscher R,
Downing TG and Kirby R: A role for mitochondrial DNA in the
pathogenesis of radiation-induced myelodysplasia and secondary
leukemia. Leuk Res. 17:907–913. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rowe TC, Weissig V and Lawrence JW:
Mitochondrial DNA metabolism targeting drugs. Adv Drug Deliv Rev.
49:175–187. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JJ, Kook H, Chung IJ, et al: Telomere
length changes in patients with aplastic anaemia. Br J Haematol.
112:1025–1030. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ball SE, Gibson FM, Rizzo S, Tooze JA,
Marsh JC and Gordon-Smith EC: Progressive telomere shortening in
aplastic anemia. Blood. 91:3582–3592. 1998.PubMed/NCBI
|
|
12
|
Brümmendorf TH, Maciejewski JP, Mak J,
Young NS and Lansdorp PM: Telomere length in leukocyte
subpopulations of patients with aplastic anemia. Blood. 97:895–900.
2001.PubMed/NCBI
|
|
13
|
Kaufman DW, Kelly JP, Levy M and Shapiro
S: The Drug Etiology of Agranulocytosis and Aplastic Anemia. Oxford
University Press; New York: 1991
|
|
14
|
Andrews RM, Kubacka I, Chinnery PF,
Lightowlers RN, Turnbull DM and Howell N: Reanalysis and revision
of the Cambridge reference sequence for human mitochondrial DNA.
Nat Genet. 23:1471999. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee MS and Levin BC: MitoAnalyzer, a
computer program and interactive web site to determine the effects
of single nucleotide polymorphisms and mutations in human
mitochondrial DNA. Mitochondrion. 1:321–326. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cawthon RM: Telomere measurement by
quantitative PCR. Nucleic Acids Res. 30:e472002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Clayton DA: Transcription of the mammalian
mitochondrial genome. Annu Rev Biochem. 53:573–594. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gattermann N: Mitochondrial DNA mutations
in the hematopoietic system. Leukemia. 18:18–22. 2004. View Article : Google Scholar
|
|
19
|
Kwok CS, Quah TC, Ariffin H, Tay SK and
Yeoh AE: Mitochondrial D-loop polymorphisms and mitochondrial DNA
content in childhood acute lymphoblastic leukemia. J Pediatr
Hematol Oncol. 33:e239–e244. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shin MG, Kajigaya S, Levin BC and Young
NS: Mitochondrial DNA mutations in patients with myelodysplastic
syndromes. Blood. 101:3118–3125. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gattermann N: From sideroblastic anemia to
the role of mitochondrial DNA mutations in myelodysplastic
syndromes. Leuk Res. 24:141–151. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Suganuma K, Miwa H, Imai N, et al: Energy
metabolism of leukemia cells: glycolysis versus oxidative
phosphorylation. Leuk Lymphoma. 51:2112–2119. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Listerman I, Sun J, Gazzaniga FS, Lukas JL
and Blackburn EH: The major reverse transcriptase-incompetent
splice variant of the human telomerase protein inhibits telomerase
activity but protects from apoptosis. Cancer Res. 73:2817–2828.
2013. View Article : Google Scholar
|
|
24
|
Lu R, Pal J, Buon L, et al: Targeting
homologous recombination and telomerase in Barrett’s
adenocarcinoma: impact on telomere maintenance, genomic instability
and tumor growth. Oncogene. 33:1495–1505. 2014.PubMed/NCBI
|
|
25
|
Begus-Nahrmann Y, Hartmann D, Kraus J, et
al: Transient telomere dysfunction induces chromosomal instability
and promotes carcinogenesis. J Clin Invest. 122:2283–2288. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Calado RT, Yewdell WT, Wilkerson KL, et
al: Sex hormones, acting on the TERT gene, increase telomerase
activity in human primary hematopoietic cells. Blood.
114:2236–2243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cooper JN, Calado R, Wu C, Scheinberg P
and Young NS: Telomere length of peripheral blood leukocytes
predicts relapse and clonal evolution after immunosuppressive
therapy in severe aplastic anemia. Blood. 112:4422008.
|
|
28
|
Scheinberg P, Wu CO, Nunez O and Young NS:
Predicting response to immunosuppressive therapy and survival in
severe aplastic anaemia. Br J Haematol. 144:206–216. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Scheinberg P, Cooper JN, Sloand EM, Wu CO,
Calado RT and Young NS: Association of telomere length of
peripheral blood leukocytes with hematopoietic relapse, malignant
transformation, and survival in severe aplastic anemia. JAMA.
304:1358–1364. 2010. View Article : Google Scholar
|
